文献速递骨软组织肉瘤与黑色素瘤泌尿男性生殖肿瘤胸部肿瘤

BAP1突变在人类癌症中的生物学机制与临床意义

Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer.
PubMed 文献 · Cancer Discov · 2020-07-20

本文综述了超过200个BAP1突变家族中BAP1癌症综合征的临床特征,几乎所有遗传BAP1突变等位基因的个体一生中发生一种或多种恶性肿瘤,主要为葡萄膜和皮肤黑色素瘤、间皮瘤及透明细胞肾细胞癌。机制研究显示BAP1的抑癌功能与其在细胞核(参与DNA修复和转录)和细胞质(调控细胞死亡和线粒体代谢)的双重活性相关,且其抑癌活性具有细胞类型和背景依赖性。

要点

  • 遗传BAP1突变个体终生恶性肿瘤风险极高,以葡萄膜/皮肤黑色素瘤、间皮瘤和透明细胞肾细胞癌为主。
  • 散发性上述肿瘤类型更易携带体细胞双等位BAP1突变。
  • BAP1抑癌功能依赖核内DNA修复/转录与胞质细胞死亡/线粒体代谢双重活性,具细胞类型依赖性。

核心结论

  • BAP1是多种癌症类型中的关键抑癌基因,胚系或体细胞突变均可促进肿瘤发生。
  • BAP1抑癌活性具有细胞类型和背景依赖性,并作为基因-环境相互作用的关键调控因子。

研究设计与样本

  • 综述性文章,汇总超过200个BAP1突变家族的临床与机制研究数据。

主要发现

  • 在超过200个BAP1突变家族中,几乎所有遗传BAP1突变等位基因的个体一生中发生一种或多种恶性肿瘤。
  • 相关肿瘤类型主要为葡萄膜和皮肤黑色素瘤、间皮瘤及透明细胞肾细胞癌。
  • 上述肿瘤类型散发性病例更可能携带体细胞双等位BAP1突变。
  • BAP1在细胞核中参与DNA修复和转录,在细胞质中调控细胞死亡和线粒体代谢。

临床怎么用

  • 对BAP1突变家族成员应关注葡萄膜/皮肤黑色素瘤、间皮瘤和透明细胞肾细胞癌的筛查与监测。
  • 散发性上述肿瘤类型患者可考虑检测体细胞BAP1双等位突变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Among more than 200 BAP1-mutant families affected by the "BAP1 cancer syndrome," nearly all individuals inheriting a BAP1 mutant allele developed one or more malignancies during their lifetime, mostly uveal and cutaneous melanoma, mesothelioma, and clear-cell renal cell carcinoma. These cancer types are also those that, when they occur sporadically, are more likely to carry somatic biallelic BAP1 mutations. Mechanistic studies revealed that the tumor suppressor function of BAP1 is linked to its dual activity in the nucleus, where it is implicated in a variety of processes including DNA repair and transcription, and in the cytoplasm, where it regulates cell death and mitochondrial metabolism. BAP1 activity in tumor suppression is cell type- and context-dependent. BAP1 has emerged as a critical tumor suppressor across multiple cancer types, predisposing to tumor development when mutated in the germline as well as somatically. Moreover, BAP1 has emerged as a key regulator of gene-environment interaction.This article is highlighted in the In This Issue feature, p. 1079.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Carbone M, Harbour JW, Brugarolas J, et al. Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer. Cancer Discov. 2020. PMID: 32690542. doi:10.1158/2159-8290.CD-19-1220

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。